Skip to main content
Erschienen in: Obesity Surgery 3/2019

07.12.2018 | Original Contributions

Changes in Body Adiposity, Dietary Intake, Physical Activity and Quality of Life of Obese Individuals Submitted to Intragastric Balloon Therapy for 6 Months

verfasst von: Marcella Rodrigues Guedes, Ricardo José Fittipaldi-Fernandez, Cristina Fajardo Diestel, Márcia Regina Simas Torres Klein

Erschienen in: Obesity Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is an important risk factor for several chronic diseases and also is associated with worse quality of life. Intragastric balloon (IGB) is an effective method for weight loss. Although changes in lifestyle are critical to weight loss during and after IGB therapy, only a few studies evaluated dietary intake and none evaluated changes in physical activity with a validated questionnaire during the treatment. The aim of this study was to evaluate changes in total and central body adiposity, dietary intake, physical activity, and quality of life of patients with obesity submitted to IGB treatment for 6 months.

Methods

Prospective observational study involving 42 patients with obesity using IGB for 6 months. The patients were evaluated, on the day of insertion and withdrawal or adjustment of IGB for total and central body adiposity (anthropometry and bioelectrical impedance), dietary intake, physical activity (Baecke questionnaire), and quality of life (SF-36 questionnaire).

Results

There was a significant decrease in total and central body adiposity. The mean % total weight loss and % excess weight loss were 15.88 ± 1.42 and 56.04 ± 4.90, respectively and waist circumference decreased 13.33 ± 1.39 cm. There was a reduction in energy intake, an increase in physical activity, and an improvement of quality of life during IGB treatment.

Conclusion

The present study suggests that IGB treatment during 6 months in individuals with obesity is effective for decreasing total and central body adiposity being associated with reduction in energy intake, increase in physical activity, and improvement in quality of life.
Literatur
1.
Zurück zum Zitat Ng M, Fleming T, Robinson M, et al. Global, regional and national prevalence on overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral Ng M, Fleming T, Robinson M, et al. Global, regional and national prevalence on overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017 377(1):13–27. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017 377(1):13–27.
3.
Zurück zum Zitat Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRefPubMed Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRefPubMed
4.
Zurück zum Zitat Bray GA, Kim KK, JPH W. World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–23.CrossRefPubMed Bray GA, Kim KK, JPH W. World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–23.CrossRefPubMed
5.
Zurück zum Zitat Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertil Steril. 2017;107(4):833–9.CrossRefPubMed Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertil Steril. 2017;107(4):833–9.CrossRefPubMed
6.
Zurück zum Zitat Kahan S, Zvenyach T. Obesity as a disease: current policies and implications for the future. Curr Obes Rep. 2016;5(2):291–7.CrossRefPubMed Kahan S, Zvenyach T. Obesity as a disease: current policies and implications for the future. Curr Obes Rep. 2016;5(2):291–7.CrossRefPubMed
7.
Zurück zum Zitat Upadhyay J, Farr O, Perakakis N, et al. Obesity as a disease. Med Clin N Am. 2018;(102):13–33. Upadhyay J, Farr O, Perakakis N, et al. Obesity as a disease. Med Clin N Am. 2018;(102):13–33.
8.
Zurück zum Zitat Pan A, Kawachi I, Luo N, et al. Changes in body weight and health-related quality of life: 2 cohorts of us women. Am J Epidemiol. 2014;180(3):254–62.CrossRefPubMedPubMedCentral Pan A, Kawachi I, Luo N, et al. Changes in body weight and health-related quality of life: 2 cohorts of us women. Am J Epidemiol. 2014;180(3):254–62.CrossRefPubMedPubMedCentral
9.
10.
Zurück zum Zitat WHO - World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Techinical Report Series (894).Geneva, 2000. WHO - World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Techinical Report Series (894).Geneva, 2000.
11.
Zurück zum Zitat Després JP. Waist circumference as a vital sign in cardiology 20 years after initial publication in the American Journal of Cardiology. Am J Cardiol. 2014;114(2):320–3.CrossRefPubMed Després JP. Waist circumference as a vital sign in cardiology 20 years after initial publication in the American Journal of Cardiology. Am J Cardiol. 2014;114(2):320–3.CrossRefPubMed
12.
Zurück zum Zitat Garvey WT, Mechanick JI, Brett EM, et al. American Association Of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity executive Summary Complete Guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016;22(7):842–84.CrossRefPubMed Garvey WT, Mechanick JI, Brett EM, et al. American Association Of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity executive Summary Complete Guidelines available at https://​www.​aace.​com/​publications/​guidelines. Endocr Pract. 2016;22(7):842–84.CrossRefPubMed
14.
Zurück zum Zitat Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–70.CrossRefPubMedPubMedCentral Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–70.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Yumuk V, Tsigos C, Fried M, et al. Obesity management task force of the european association for the study of obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402–24.CrossRefPubMedPubMedCentral Yumuk V, Tsigos C, Fried M, et al. Obesity management task force of the european association for the study of obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402–24.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Ali MR, Moustarah F, Kim JJ. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Obes Relat Dis. 2016;12(3):462–7.CrossRefPubMed Ali MR, Moustarah F, Kim JJ. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Obes Relat Dis. 2016;12(3):462–7.CrossRefPubMed
17.
Zurück zum Zitat Laing P, Pham T, Taylor LJ, et al. Filling the void: a review of intragastric balloons for obesity. Dig Dis Sci. 2017;62(6):1399–408.CrossRefPubMed Laing P, Pham T, Taylor LJ, et al. Filling the void: a review of intragastric balloons for obesity. Dig Dis Sci. 2017;62(6):1399–408.CrossRefPubMed
18.
Zurück zum Zitat Neto MG, Silva LB, Grecco E, de Quadros LG, Teixeira A, Souza T et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2017;28. pii: S1550–S7289. Neto MG, Silva LB, Grecco E, de Quadros LG, Teixeira A, Souza T et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2017;28. pii: S1550–S7289.
19.
20.
Zurück zum Zitat Yorke E, Switzer NJ, Reso A, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26(9):2248–54.CrossRefPubMed Yorke E, Switzer NJ, Reso A, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26(9):2248–54.CrossRefPubMed
21.
Zurück zum Zitat Donadio F, Sburlati LF, Masserini B, et al. Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients. J Endocrinol Investig. 2009;32(2):165–8.CrossRef Donadio F, Sburlati LF, Masserini B, et al. Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients. J Endocrinol Investig. 2009;32(2):165–8.CrossRef
22.
Zurück zum Zitat Karagiozoglou-Lampoudi T, Papakostas P, Penna S, et al. Effective intragastric balloon treatment in obese adolescents. Ann Gastroenterol. 2009;22(1):46–51. Karagiozoglou-Lampoudi T, Papakostas P, Penna S, et al. Effective intragastric balloon treatment in obese adolescents. Ann Gastroenterol. 2009;22(1):46–51.
23.
Zurück zum Zitat Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.CrossRefPubMed Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.CrossRefPubMed
24.
Zurück zum Zitat Fuller NR, Lau NS, Denyer G, et al. An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clin Obes. 2013;3(6):172–9.CrossRefPubMed Fuller NR, Lau NS, Denyer G, et al. An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clin Obes. 2013;3(6):172–9.CrossRefPubMed
25.
Zurück zum Zitat Genco A, Maselli R, Cipriano M, et al. Long-term multiple intragastric balloon treatment—a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow-up study. Surg Obes Relat Dis. 2014;10(2):307–11.CrossRef Genco A, Maselli R, Cipriano M, et al. Long-term multiple intragastric balloon treatment—a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow-up study. Surg Obes Relat Dis. 2014;10(2):307–11.CrossRef
26.
Zurück zum Zitat Courcoulas A, Abu Dayyeh BK, Eaton L, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes. 2017;41(3):427–33.CrossRef Courcoulas A, Abu Dayyeh BK, Eaton L, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes. 2017;41(3):427–33.CrossRef
27.
Zurück zum Zitat Guedes EP, Madeira E, Mafort TT, et al. Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome. Health Qual Life Outcomes. 2017;15:211.CrossRefPubMedPubMedCentral Guedes EP, Madeira E, Mafort TT, et al. Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome. Health Qual Life Outcomes. 2017;15:211.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Reimão SM, da Silva MER, Nunes GC, et al. Improvement of body composition and quality of life following intragastric balloon. Obes Surg. 2018;28(6):1806–8.CrossRefPubMed Reimão SM, da Silva MER, Nunes GC, et al. Improvement of body composition and quality of life following intragastric balloon. Obes Surg. 2018;28(6):1806–8.CrossRefPubMed
29.
Zurück zum Zitat Kyle UG, Bosaeus I, Lorenzo ADD, et al. Bioelectrical impedance analysis part I: review of principles and methods. ESPEN Guidelines Clin Nutr. 2004;23:1226–43.CrossRefPubMed Kyle UG, Bosaeus I, Lorenzo ADD, et al. Bioelectrical impedance analysis part I: review of principles and methods. ESPEN Guidelines Clin Nutr. 2004;23:1226–43.CrossRefPubMed
30.
Zurück zum Zitat Fittipaldi-Fernandez RJ, Guedes MR, Galvao Neto MP, et al. Efficacy of intragastric balloon treatment for adolescent obesity. Obes Surg. 2017;27(10):2546–51.CrossRefPubMed Fittipaldi-Fernandez RJ, Guedes MR, Galvao Neto MP, et al. Efficacy of intragastric balloon treatment for adolescent obesity. Obes Surg. 2017;27(10):2546–51.CrossRefPubMed
31.
Zurück zum Zitat Tai CM, Lin HY, Yen YC, et al. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obes Surg. 2013;23(12):2068–74.CrossRefPubMed Tai CM, Lin HY, Yen YC, et al. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obes Surg. 2013;23(12):2068–74.CrossRefPubMed
32.
Zurück zum Zitat Mitura K, Garnysz K. Tolerance of intragastric balloon and patient’s satisfaction in obesity treatment. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):445–9.PubMedPubMedCentral Mitura K, Garnysz K. Tolerance of intragastric balloon and patient’s satisfaction in obesity treatment. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):445–9.PubMedPubMedCentral
34.
Zurück zum Zitat Ribeiro da Silva J, Proença L, Rodrigues A, et al. Intragastric balloon for obesity treatment: safety, tolerance, and efficacy. GE Port J Gastroenterol. 2018;25(5):236–42.CrossRefPubMed Ribeiro da Silva J, Proença L, Rodrigues A, et al. Intragastric balloon for obesity treatment: safety, tolerance, and efficacy. GE Port J Gastroenterol. 2018;25(5):236–42.CrossRefPubMed
36.
Zurück zum Zitat Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011;19(5):1083–9.CrossRefPubMedCentral Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011;19(5):1083–9.CrossRefPubMedCentral
37.
Zurück zum Zitat Zhou JY, Ge H, Zhu M, et al. Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol. 2013;12(76):2–7. Zhou JY, Ge H, Zhu M, et al. Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol. 2013;12(76):2–7.
38.
Zurück zum Zitat Segal KR, Van Loan M, Fitzgerald PI, et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-Validation study. Am J Clin Nutr. l988;47:7–14. Segal KR, Van Loan M, Fitzgerald PI, et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-Validation study. Am J Clin Nutr. l988;47:7–14.
39.
Zurück zum Zitat Gray DS, Bray GA, Gemayel N, et al. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. l989;50:–255, 60. Gray DS, Bray GA, Gemayel N, et al. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. l989;50:–255, 60.
40.
Zurück zum Zitat Sichieri R, Everhart JE. Validity of a brazilian food frequency questionnaire against dietary recalls and estimated energy intake. Nutr Res. 1998;18(10):1649–59.CrossRef Sichieri R, Everhart JE. Validity of a brazilian food frequency questionnaire against dietary recalls and estimated energy intake. Nutr Res. 1998;18(10):1649–59.CrossRef
41.
Zurück zum Zitat Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936–42.CrossRefPubMed Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936–42.CrossRefPubMed
42.
Zurück zum Zitat Florindo AA, Latorre MRDO. Validação e reprodutibilidade do questionário de Baecke de avaliação da atividade física habitual em homens adultos. Rev Bras Med Esporte. 2003;9(3):121–8.CrossRef Florindo AA, Latorre MRDO. Validação e reprodutibilidade do questionário de Baecke de avaliação da atividade física habitual em homens adultos. Rev Bras Med Esporte. 2003;9(3):121–8.CrossRef
43.
Zurück zum Zitat Ciconelli RM, Ferraz MB, Santos W, et al. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39(3):143–50. Ciconelli RM, Ferraz MB, Santos W, et al. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39(3):143–50.
44.
Zurück zum Zitat Al-Sabah S, Al-Ghareeb F, Ali DA, et al. Efficacy of intragastric balloon for the management of obesity: experience from Kuwait. Surg Endosc. 2016;30(2):424–9.CrossRefPubMed Al-Sabah S, Al-Ghareeb F, Ali DA, et al. Efficacy of intragastric balloon for the management of obesity: experience from Kuwait. Surg Endosc. 2016;30(2):424–9.CrossRefPubMed
45.
Zurück zum Zitat Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12(2):420–9.CrossRefPubMed Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12(2):420–9.CrossRefPubMed
46.
Zurück zum Zitat Nunes GC, Pajecki D, de Melo ME, et al. Assessment of weight loss with the intragastric balloon in patients with different degrees of obesity. Surg Laparosc Endosc Percutan Tech. 2017;27(4):e83–6.CrossRefPubMed Nunes GC, Pajecki D, de Melo ME, et al. Assessment of weight loss with the intragastric balloon in patients with different degrees of obesity. Surg Laparosc Endosc Percutan Tech. 2017;27(4):e83–6.CrossRefPubMed
47.
Zurück zum Zitat Mafort TT, Madeira E, Madeira M, et al. Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome. Obes Surg. 2014;24(2):232–40.CrossRefPubMed Mafort TT, Madeira E, Madeira M, et al. Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome. Obes Surg. 2014;24(2):232–40.CrossRefPubMed
48.
Zurück zum Zitat Zheng Y, Wang M, He S, et al. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med. 2015;13:246.CrossRefPubMedPubMedCentral Zheng Y, Wang M, He S, et al. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med. 2015;13:246.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Hall K, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin N Am. 2018;102:183–97.CrossRefPubMed Hall K, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin N Am. 2018;102:183–97.CrossRefPubMed
Metadaten
Titel
Changes in Body Adiposity, Dietary Intake, Physical Activity and Quality of Life of Obese Individuals Submitted to Intragastric Balloon Therapy for 6 Months
verfasst von
Marcella Rodrigues Guedes
Ricardo José Fittipaldi-Fernandez
Cristina Fajardo Diestel
Márcia Regina Simas Torres Klein
Publikationsdatum
07.12.2018
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3609-x

Weitere Artikel der Ausgabe 3/2019

Obesity Surgery 3/2019 Zur Ausgabe

Letter to the Editor

Botox or No-Tox?

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.